BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

ARKGvsBBPETF Comparison

ETF 1

ARKG

ARK Genomic Revolution ETF

This fund is part of

BioTech & Genomics

-0.01%

Full ARKG fund page

VS

ETF 2

BBP

Virtus LifeSci Biotech Products ETF

This fund is part of

Tomorrow's Treatments

-0.42%

Full BBP fund page

ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, BBP's top sector exposures are Health Care ARKG is less expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.79% for BBP. ARKG is up 2.37% year-to-date (YTD) with +$35M in YTD flows. BBP performs better with 6.19% YTD performance, and +$12M in YTD flows. Run a side-by-side ETF comparison of ARKG and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

ARKG vs BBP performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 04/30/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	ARKG BBP	+20.56%+8.06%	-1.72%+3.81%	+2.37%+6.19%	+35.83%+43.52%	+2.31%+62.62%	-66.16%+57.43%
Flows	ARKG BBP	+$50M+$4M	+$8M+$12M	+$35M+$12M	-$14M+$24M	-$531M+$27M	-$3.01B+$17M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	ARKG BBP	+43.80%+28.33%	+41.90%+24.01%	+42.68%+23.74%	+45.42%+26.19%
Max drawdown	ARKG BBP	-19.13%-9.59%	-27.52%-9.81%	-51.98%-25.54%	-80.16%-38.24%
Max drawdown duration	ARKG BBP	73d48d	98d36d	1016d292d	1766d915d

Trading data

Create an account to view trading data

Join for free

	ARKG	BBP
Last sale 5/1/2026 at 1:30 PM	$30.30	$84.97
Previous close 04/29/2026	$29.87	$84.78
Consolidated volume 04/29/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of April 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	ARKG	BBP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 5/1/2026 at 1:30 PM

Live

Closed

	ARKG	BBP
Last price	$30.30	$84.97
1D performance	+1.44%	+0.22%
AuM	$1.24 B	$59.29 M
E/R	0.75%	0.79%

Characteristics

	ARKG	BBP
Management strategy	Active	Passive
Provider	Ark Investment	VIRTUS Investment Partners
Benchmark	-	LifeSci Biotechnology Products Index
N° of holdings	27	56
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	April 2, 2019	December 16, 2014
ESG	No	No

More ARKG data on Trackinsight

More BBP data on Trackinsight

Exposure

Countries

ARKG

USA

70.4%

Switzerland

9.23%

Other

20.37%

BBP

USA

89.45%

Other

10.55%

Sectors

ARKG

Health Care

78.38%

Other

21.62%

BBP

Health Care

88.78%

Other

11.22%

Diversification

ARKG

Total weight of top 15 holdings out of 15

62.5%

BBP

Total weight of top 15 holdings out of 15

33.42%

Top 15 holdings

Data as of March 31, 2026

ARKG

CRISPR THERAPEUTICS

9.23%

10X GENOMICS INC

6.30%

BEAM THERAPEUTICS

4.86%

PERSONALIS INC

4.69%

NATERA

4.48%

ILLUMINA

4.45%

GUARDANT HEALTH INC

4.21%

INTELLIA THERAPEUTICS INC

3.58%

CAREDX INC/D

3.56%

RECURSION PHARMACEUTICALS

3.54%

ABSCI

3.27%

VERACYTE INC/D

2.98%

ADAPTIVE BIOTECHNOLOGIES

2.71%

NURIX THERAPEUTICS

2.45%

SEMA4 HOLDINGS CORP

2.19%

BBP

BIOCRYST PHARMACEUTICALS

2.50%

ROIVANT SCIENCES LTD

2.45%

SYNDAX PHARMACEUTICALS INC

2.40%

GILEAD SCIENCES

2.25%

GERON

2.24%

GB00BRXB0C07

2.23%

KALVISTA PHARMACEUTICALS INC

2.22%

AMGEN-T

2.20%

AXSOME THERA CMN STK

2.20%

AGIOS PHARMA/D

2.18%

BIOGEN INC

2.17%

UTD THERAPEUT

2.13%

LIGAND PHARMACEUTICALS

2.13%

BIOMARIN PHARMACEUTICAL

2.06%

EXELIXIS

2.05%

Frequently asked questions about ARKG and BBP

How have the ARKG and BBP ETFs performed in 2026?

As of April 30, 2026, ARKG is up 2.37% year-to-date (YTD), while BBP has returned 6.19%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or BBP?

Year-to-date, the ARKG ETF saw +$35M in flows, compared to +$12M for BBP.

Which ETF is more volatile: ARKG or BBP?

Over the past year, ARKG had a volatility of 41.9%, while BBP experienced 24.01%.

Which ETF is bigger: ARKG or BBP?

As of April 30, 2026, ARKG holds $1.24 B in assets under management (AUM), while BBP manages $59.29 M.

What sectors do the ARKG and BBP ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.

What are the top holdings of the ARKG ETF and BBP ETF?

ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. BBP holds in its top three: BIOCRYST PHARMACEUTICALS, ROIVANT SCIENCES LTD and SYNDAX PHARMACEUTICALS INC.

Which ETF is more diversified: ARKG or BBP?

ARKG holds 27 securities with 62.5% of its assets in the top 15. BBP has 61 securities and a top 15 weight of 33.42%.

Biotech ETFs – Investing in Health Innovation

July 21, 2022

ARKG

ARKGvsBBPETF Comparison

ARK Genomic Revolution ETF

Virtus LifeSci Biotech Products ETF

ARKG vs BBP performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the ARKG and BBP ETFs performed in 2026?

As of April 30, 2026, ARKG is up 2.37% year-to-date (YTD), while BBP has returned 6.19%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or BBP?

Year-to-date, the ARKG ETF saw +$35M in flows, compared to +$12M for BBP.

Which ETF is more volatile: ARKG or BBP?

Over the past year, ARKG had a volatility of 41.9%, while BBP experienced 24.01%.

Which ETF is bigger: ARKG or BBP?

As of April 30, 2026, ARKG holds $1.24 B in assets under management (AUM), while BBP manages $59.29 M.

What sectors do the ARKG and BBP ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.

What are the top holdings of the ARKG ETF and BBP ETF?

ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. BBP holds in its top three: BIOCRYST PHARMACEUTICALS, ROIVANT SCIENCES LTD and SYNDAX PHARMACEUTICALS INC.

Which ETF is more diversified: ARKG or BBP?

ARKG holds 27 securities with 62.5% of its assets in the top 15. BBP has 61 securities and a top 15 weight of 33.42%.

Biotech ETFs – Investing in Health Innovation

Build and Analyze Your ETF Portfolio Like a Pro